40
NPS Score
VS
Alnylam Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 23
- TOTAL
RATINGS
Moderna Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 67
- TOTAL
RATINGS
Alnylam Pharmaceuticals vs Moderna Therapeutics
Compare Alnylam Pharmaceuticals versus Moderna Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 23 employees and customers of Alnylam Pharmaceuticals and 67 employees and customers of Moderna Therapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Alnylam Pharmaceuticals. Their current market cap is $24.72B.
Moderna Therapeutics
Moderna Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Moderna Therapeutics. Their current valuation is $69.15B.
3.9/5
Product Quality
2.9/5
3.5/5
Pricing
3.1/5
3.4/5
Customer Service
3.1/5
| 70% | Promoters |
|---|---|
| 0% | Passive |
| 30% | Detractors |
Net Promoter Score
Winner by 68
-28
NPS Score
| 29% | Promoters |
|---|---|
| 14% | Passive |
| 57% | Detractors |
See how Alnylam Pharmaceuticals compares to its competitors
Working at Alnylam Pharmaceuticals vs Working at Moderna Therapeutics
78 / 100
CEO Rating
Winner by 29%
49 / 100
CEO Rating
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Moderna Therapeutics
Employees at Moderna Therapeutics rate their CEO, Stéphane Bancel, 49/100. This score is 29% lower than the scores of Alnylam Pharmaceuticals' CEO, John Maraganore.